INGRANULES Stock Latest News
Company AnnouncementsGranules India’s Gagillapur Plant Clears USFDA GMP Inspection With Eleven Observations2d ago
Company AnnouncementsGranules India forms wholly owned Brazilian pharma subsidiary1M ago
Company AnnouncementsGranules India Plans Webinar to Detail ‘Granules 2.0’ Transformation Strategy1M ago
Company AnnouncementsGranules India Publishes Q1 FY27 Earnings Call Transcript for Investors3M ago- Company AnnouncementsGranules India Wins Sole First-to-File Status for U.S. Sodium Oxybate Generic3M ago
Company AnnouncementsGranules India Files Monitoring Report on Preferential Issue Proceeds for Q4 FY266M ago
Company AnnouncementsGranules India Subsidiary Clears Routine USFDA cGMP Audit With Procedural Observations7M ago
Company AnnouncementsGranules Life Sciences Gets US FDA VAI Rating for Shamirpet Plant7M ago
Company AnnouncementsGranules India’s US Packaging Facility Clears Second FDA Inspection With NAI Status8M ago
Company AnnouncementsGranules India Issues Corrigendum on EGM Notice for Preferential Issue9M ago
Company AnnouncementsGranules’ US Arm Wins FDA Tentative Nod and 180-Day Exclusivity for Generic ADHD Drug9M ago
Company AnnouncementsGranules India Board Clears Rs 1,762-Crore Preferential Fundraise, Calls January EGM10M agoCompany AnnouncementsGranules India Subsidiary Wins FDA Tentative Nod for Generic ADHD ODT Drug10M ago
Company AnnouncementsGranules India Subsidiary Receives US FDA Inspection Report12M ago
Company AnnouncementsGranules India Allots 25,000 Shares Under ESOS 20171y ago- Company AnnouncementsGranules India Releases Q1 FY26 Earnings Call Transcript1y ago
Company AnnouncementsGranules India Limited Announces Change in Registered Office Location1y ago
Company AnnouncementsGranules India Allots 50,000 Shares Under ESOS 20091y ago